Client Engagement · Anonymized

$18M+ in new revenue from expansion sequenced by evidence, not ambition

Sector: B2B products & servicesFocus: Market expansionMethod: Decide → Drive emphasis

$18M+

New revenue generated

Markets entered successfully

Candidate markets deliberately declined

The situation

A company with a proven model in its home market and a leadership team eager to expand — into roughly a dozen candidate markets at once. Ambition was high, capital was finite, and the expansion plan was effectively a wish list ranked by enthusiasm. The classic failure mode was fully loaded: enter everywhere thinly, win nowhere decisively.

Diagnose: what actually made the home market work

Before evaluating a single new market, the diagnostic decomposed the home-market success into its drivers: which customer segments carried the economics, what channel dynamics enabled acquisition at viable cost, and which local conditions — competitive gaps, regulatory posture, partner availability — were prerequisites versus nice-to-haves. This produced a transferability scorecard: the honest list of what the model needed to work anywhere.

Decide: five markets, seven noes

Each candidate market was scored against the transferability criteria with real field data, not desk optimism. Five-plus markets cleared the bar. Seven did not — including two that leadership had emotionally pre-committed to. Declining those seven was the single most valuable decision of the engagement: the capital and management attention they would have consumed funded proper entries into the markets that qualified.

Design: an entry playbook, not five improvisations

Rather than five bespoke launches, the roadmap built one repeatable entry playbook — localized offer, channel partner criteria, 90-day launch sequence, and explicit success/kill metrics at day 90 and day 180. Each market got the playbook plus deliberate local adaptations, documented so the next entry got smarter.

Drive: kill criteria with teeth

The operating cadence reviewed each market against its stage-gate metrics monthly. One early entry tracked below its day-90 threshold; the playbook's response — a defined pivot of channel strategy rather than quiet budget increases — recovered it. The discipline of pre-agreed criteria removed the politics from expansion decisions. Cumulative result: $18M+ in new revenue across the entered markets.

What moved

$18M+ in new revenue across five-plus successfully entered markets
Zero failed entries requiring write-off — the kill criteria worked before capital was sunk
A reusable expansion playbook that reduced each subsequent entry's cost and time

The founder-transferable lesson: expansion strategy is mostly subtraction. The markets you decline fund the markets you win. If your expansion list has no rejected candidates, it isn't a strategy — it's a hope with a budget.

Disclosure: This describes a real engagement. Identifying details — sector specifics, company scale, and timeline — have been altered to protect client confidentiality. Results figures are as achieved.

Discuss Your Expansion Plan All Case Studies

How the work was actually run

The 4D Method →

Decompose the home market before evaluating any other

Which segments carried the economics, what channel dynamics made it work, which capabilities were genuinely transferable. Expansion decisions made without this are effectively assuming the new market resembles the old one in ways nobody has tested.

Size bottom-up, never from an analyst figure

Addressable units, trigger conditions, current spend on the alternative, defensible capture rate. Top-down sizing with an assumed share is the single most common way an expansion case is inflated, and it inflates it early enough that everything downstream inherits the error.

Map the profit pool, not just the market

Where money is actually made along the value chain, and whether the position you plan to occupy is one of those places. A large market where all the profit sits with a different participant is not an opportunity.

Score entry modes on reversibility, not just return

Direct, partner, channel, acquire, licence. In an uncertain market, an option you can exit cheaply is frequently worth more than one with higher modelled return and no exit.

What transferred

The part that repeated elsewhere

The most useful output of any engagement is the portion that turns out to generalise. That portion is what eventually becomes a repeatable product rather than a one-off.

Declining markets is the deliverable. Seven candidate markets were deliberately turned down. The capital and management attention that would have gone into thin entries went into decisive ones instead, and the concentration is what produced the result.

Localization is not translation. Product, pricing, commercial terms, support model and go-to-market motion each need examining separately. Companies routinely translate the interface and change nothing about the commercial model, then conclude the market does not want the product.

Staged entry with real exit criteria preserves the option to stop. Once entry is announced with no defined exit condition, stopping becomes a reputational event rather than a decision, and organisations will fund a failing market for years to avoid it.

Limitations

What this case does not prove

This company had a genuinely proven model at home and capital available to concentrate. Both were preconditions. A company whose home market is unresolved is not ready for this analysis, and the honest recommendation in that situation is to fix the core before extending it.

Market entry outcomes also depend heavily on execution and partner selection after the strategic decision, which is a longer horizon than a diagnostic engagement covers.

Client identity, sector detail and absolute figures are withheld or adjusted under confidentiality. Cases are labelled either Client Engagement · Anonymized or Composite Case, and the distinction is never blurred — a composite presented as a client story would undermine everything else on this site.

Questions

On this engagement

How many markets should we enter at once?

Fewer than the list you arrive with, almost always. The binding constraint is rarely capital — it is management attention, which does not scale and is not fungible. Two decisive entries reliably outperform six thin ones, and the six-thin pattern is how companies end up present everywhere and winning nowhere.

What if we have already entered a market that is not working?

Then the question is whether it was ever going to work or whether it was under-resourced, and that is answerable with the same analysis applied retrospectively. Both answers are useful: one justifies a decisive exit, the other justifies concentration. What is not useful is the middle position of continuing to fund it at a level that cannot succeed.

Your situation is not this one.

Which is the point of the audit — thirty minutes establishing what is actually binding in your business, before anyone proposes a solution shaped like someone else's.

Book a Call More case studies

$18M+ in new revenue from expansion sequenced by evidence, not ambition

The situation

Diagnose: what actually made the home market work

Decide: five markets, seven noes

Design: an entry playbook, not five improvisations

Drive: kill criteria with teeth

What moved

How the work was actually run

Decompose the home market before evaluating any other

Size bottom-up, never from an analyst figure

Map the profit pool, not just the market

Score entry modes on reversibility, not just return

The part that repeated elsewhere

What this case does not prove

On this engagement

Related

Market Entry & Expansion

Growth & Corporate Strategy

Pricing & Profitability

Your situation is not this one.